French startup Ÿnsect shot into the highlight when “Iron Man” star Robert Downey Jr. touted its merits on the Late Present throughout Tremendous Bowl weekend 2021. Now, almost 4 years later, the insect farming firm has been placed into judicial liquidation — primarily chapter — for insolvency.
The corporate’s demise is hardly a shock, as Ÿnsect had been embattled for months. Nonetheless, there’s loads to unpack about how a startup can go bankrupt regardless of elevating over $600 million, together with from Downey Jr’s FootPrint Coalition, taxpayers, and plenty of others.
Finally, Ÿnsect failed to meet its ambition to “revolutionize the food chain” with insect-based protein. However don’t be too fast to attribute its failure to the ‘ick’ issue that many Westerners really feel about bugs. Human meals was by no means its core focus.
As an alternative, Ÿnsect centered on producing insect protein for animal feed and pet meals, two markets with very totally different economics and margins that the corporate by no means fairly selected between.
That indecision prolonged to its M&A technique. In 2021, Ÿnsect acquired Protifarm, a Dutch firm elevating mealworms for human meals purposes, including a 3rd market to the combo. Whilst the corporate introduced the deal, then-CEO Antoine Hubert admitted it might take a few years for human meals to signify simply 10% to fifteen% of Ÿnsect’s income.
“We nonetheless see pet meals and fish feed being the biggest contributor to our revenues within the coming years,” Hubert declared on the time. In different phrases, Ÿnsect was buying an organization in a market phase that may stay marginal for years — at a time when the startup desperately wanted income progress.
And income was the issue. In keeping with publicly obtainable knowledge, Ÿnsect’s income from its foremost entity peaked at €17.8 million in 2021 (roughly $21 million) — a determine reportedly inflated by internal transfers between subsidiaries. By 2023, the corporate had racked up a web lack of €79.7 million ($94 million).
Techcrunch occasion
San Francisco
|
October 13-15, 2026
So how did an organization with such meager income elevate over $600 million? The reply wasn’t hype-driven crossover funds paying bold multiples through the 2021 funding frenzy. As an alternative, Ÿnsect attracted impact-focused buyers like Astanor Ventures and public funding financial institution Bpifrance that purchased right into a compelling sustainability imaginative and prescient.
Its pitch to them was easy — providing a substitute for resource-intensive proteins like fishmeal and soy. That very same thesis additionally attracted vital capital to opponents like Higher Origin and Innovafeed, and it appeared promising.
However the imaginative and prescient collided with market actuality. Animal feed is a commodity market pushed by value, not sustainability premiums. In an ideal world, insect protein can be totally round, with bugs ate up meals waste that may in any other case go to landfill. However in observe, factory-scale insect manufacturing usually finally ends up relying on cereal byproducts which are already usable as animal feed — that means insect protein simply provides an costly further step. For animal feed, the maths merely wasn’t working.
Ÿnsect ultimately acknowledged this. Pet meals proved to be a unique equation: it’s much less price-driven than animal feed and a much better marketplace for insect protein, even with competitors from different various proteins comparable to lab-grown meat. By 2023, the corporate refocused its strategy on pet meals and different higher-margin segments, with Hubert citing broader financial pressures.
“In an atmosphere the place there’s inflation on power and uncooked supplies but additionally on the price of capital and debt, we can not afford to speculate a great deal of sources in markets that are the least remunerative (animal feed), when you produce other markets the place there’s numerous demand, good returns and better margins,” Hubert stated on the time.
The 2023 pivot to pet meals got here too late. By then, Ÿnsect had already dedicated to an enormous, capital-intensive wager that may finally doom the corporate. That wager was Ÿnfarm, a “giga-factory” in Northern France that the corporate billed “the world’s most costly bug farm.” Constructed for insect manufacturing at scale, the power consumed a whole bunch of thousands and thousands in funding — cash spent earlier than Ÿnsect had confirmed its enterprise mannequin or discovered its unit economics.
To supervise Ÿnfarm’s launch, Ÿnsect introduced in Shankar Krishnamoorthy, a former govt at French power big Engie. When that transfer to pet meals failed to save lots of the corporate, Krishnamoorthy changed Hubert as CEO.
Ÿnsect then shut down the manufacturing plant it had acquired from Protifarm and reduce jobs. However shuttering one facility whereas working a giga-factory constructed for the incorrect market couldn’t clear up the elemental drawback.
For Professor Joe Haslam, who teaches a course on Scaling Up within the MBA Program at IE Enterprise College, “Ÿnsect’s struggles will not be a thriller and never primarily about bugs. They’re the results of a mismatch between industrial ambition, capital markets, and timing, compounded by some execution and technique selections.”
The truth that Ÿnsect failed doesn’t imply the complete insect farming sector is doomed. Competitor Innovafeed is reportedly holding up better, partly as a result of it began with a smaller manufacturing web site and is ramping up incrementally.
For Prof. Haslam, Ÿnsect exemplifies a broader European drawback. “Ÿnsect is a case examine in Europe’s scaling hole. We fund moonshots. We underfund factories. We rejoice pilots. We abandon industrialization. See Northvolt [a struggling Swedish battery maker], Volocopter [a German air taxi startup, and Lilium [a failed Germany flying taxi company],” he stated.
The failure has prompted some soul-searching. Hubert himself co-founded Start Industrie, an affiliation advocating for insurance policies to help French industrial startups — a recognition that Europe wants extra than simply funding to construct the following era of deep-tech corporations.

